The introduction of 'chemotherapy' using arsphenamine - The first magic bullet

Journal of the Royal Society of Medicine

Volumn 102, Issue 8, 2009, Pages 343-348

  Williams, K J ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARSPHENAMINE; NEOARSPHENAMINE; PENICILLIN G;

DRUG INDUSTRY; DRUG MANUFACTURE; DRUG SCREENING; HISTORY OF MEDICINE; HUMAN; NONHUMAN; REVIEW; SYPHILIS; TREPONEMA PALLIDUM; UNITED KINGDOM;

EID: 68949083062     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.2009.09k036     Document Type: Review

References (21)

1. Ehrlich P. Experimental researches on specific therapy. On immunity with special relationship between distribution and action of antigens. Harben Lecture. London: Lewis; 1908
2. Witkop B. Paul Ehrlich and his magic bullets - revisited. Lecture given at the Paul Ehrlich Foundation, Frankfurt, 13 November 1998. See http://www.aps-pub.com/ proceedings/1434/Witkop
3. Abraham JJ. Some account of the history of the treatment of syphilis. Br J Venereal Diseases 1948;24:153-161
4. Alt K. Behandlungsversuche mit Arsenophenylglyzin bei Paralytikern. Muenchener Medizinische Wochenschrift 1909;56:1457-1459
5. Wechselmann W. Über die Behandlung der Syphilis mit Dioxydiamido-arseno-benzol. Berliner Klinische Wochenschrift 1910;47:1261-1264
6. Baumler E. Paul Ehrlich. Scientist for life. New York, NY: Holmes & Meier; 1984
7. McDonagh JER. Salvarsan in syphilis and allied diseases. Oxford: Oxford Medical Publications; 1912
8. McDonagh JER. Some toxic effects of Salvarsan. BMJ 1912;1:272
9. McDonagh JER. The manufacture of Salvarsan products in England and France. BMJ 1915;1:697
10. McDonagh JER. The manufacture of Salvarsan products in England and France. BMJ 1915;1:742
11. McDonagh JER. The chemio-therapeutics of Mr McDonagh. BMJ 1916;2:340-341
12. Williams DI. Short History of the London Lock Hospital and Rescue Home 1746-1906. London: Lock Hospital; 1906
13. Yakimoff WL, Kohl-Yakimoff N. Der Einfluss von Mikroben auf dieWirkung des Salvarsan. Muenchener Medizinische Wochenschrift 1911;58:2601-2604
14. Williams KJ. British pharmaceutical industry, synthetic drug manufacture and the clinical testing of novel drugs 1895-1939. PhD thesis. Manchester: University of Manchester; 2005
15. Church RA, Tansey EM. Burroughs, Wellcome & Co., Knowledge, Trust and Profit, and the transformation of the British pharmaceutical industry. Lancaster: Carnegie Publishing; 2007
16. Editorial. The manufacture of Salvarsan products in England and France. BMJ 1915;10 April:1091
17. Lucey HC. The therapeutic and reaction effects of Kharsivan; a record of 600 injections. BMJ 1916;1:614-616
18. Medical Research Council. 5th Annual Report. London; MRC; 1922
19. Cox-Maximov D. The making of the clinical trial in Britain, 1910-1945: expertise, the state and the public. PhD thesis. Cambridge: University of Cambridge; 1997
20. Toth B. Clinical trials in British medicine 1848-1948, with special reference to the development of the randomised controlled trial. PhD thesis. Bristol: University of Bristol; 1998
21. Benedek T. The 'Tuskegee Study' of syphilis: analysis of moral versus methodologic aspects. In: Reverby SM, ed. Tuskegee's truths: rethinking the Tuskegee Syphilis Study. Chapel Hill, NC: University of North Carolina Press; 2000. p. 213-235